AMGN · 10-Q · 2026Q3 · Full report

Capital Return Program

AMGEN INC · 2026-11-04 · Importance 43 · Surprise 32 · In source text

Amgen paid $4.1 billion of dividends during the nine months ended September 30, 2026, compared with $3.8 billion in the prior-year period. The Board declared quarterly dividends of $2.52 per share for each of the first three quarters of 2026, a 6% increase over the corresponding 2025 payments. In October 2026, the Board declared another $2.52-per-share dividend, payable in December 2026. Amgen did not repurchase shares under its stock repurchase program during the first nine months of 2026, and $6.8 billion of authorization remained available at September 30, 2026.

Key facts

• In October 2026, Amgen declared a quarterly cash dividend of $2.52 per share, payable in December 2026. source
• In October 2026, Amgen's Board declared a quarterly cash dividend of $2.52 per share, payable in December 2026. source
• Amgen declared dividends of $2.52 per share for the three and nine months ended September 30, 2026, totaling $1.396 billion and $2.758 billion, respectively. source
• Amgen declared quarterly cash dividends of $2.52 per share for the first, second and third quarters of 2026, paid in March, June and September 2026, respectively. source
• Amgen's Board declared quarterly cash dividends of $2.52 per share for the first, second, and third quarters of 2026, a 6% increase over the same prior-year periods; the dividends were paid in March, June, and September 2026. source
• Amgen intends to continue investing in its business while returning capital to stockholders through cash dividends and stock repurchases. source

Impact estimates